SCHEMBL23745692

SCHEMBL23745692

O=C(CC(c1cccnc1)c1cn(Cc2ccccc2)c2ccccc12)NCCC1CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
ITGB3 P05106 7/20 0.41
ITGA2B P08514 7/20 0.41
ALDH1A1 P00352 3/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 1/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
HTR2C P28335 1/20 0.41
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23721860 0.99 LMNA (0.41) LMNASMN1; SMN2HPGDHTTITGB3
SCHEMBL23745452 0.86 BCHE (0.42) LMNASMN1; SMN2ITGB3ITGA2BALDH1A1
Hydrochloric Acid SCHEMBL22439438 0.85 BCHE (0.42) LMNASMN1; SMN2ITGB3ITGA2BALDH1A1
SCHEMBL23745676 0.85 ALDH1A1 (0.39) ITGB3ITGA2BALDH1A1BCHEACHE
Hydrochloric Acid SCHEMBL23722185 0.84 ALDH1A1 (0.39) ITGB3ITGA2BALDH1A1BCHEACHE
SCHEMBL23745669 0.84 ACHE (0.45) BCHEACHEMAPT
Hydrochloric Acid SCHEMBL23721994 0.83 ACHE (0.44) BCHEACHEMAPT
SCHEMBL23745527 0.82 USP2 (0.45) ALDH1A1USP2POLBHSD17B10BCHE
SCHEMBL23745653 0.82 SMN1; SMN2 (0.45) LMNASMN1; SMN2HPGDHTTALDH1A1
Hydrochloric Acid SCHEMBL23721948 0.82 USP2 (0.45) ALDH1A1USP2POLBHSD17B10BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 LMNA 2573/4885SMN1; SMN2 4414/4885HPGD 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.